LBA6 KRYSTAL-1: Adagrasib (MRTX849) as monotherapy or combined with cetuximab (Cetux) in patients (Pts) with colorectal cancer (CRC) harboring a KRASG12C mutation

Authors:
  • JWJ. Weiss
    J. Weiss
  • RYR.D. Yaeger
    R.D. Yaeger
  • MJM.L. Johnson
    M.L. Johnson
  • ASA. Spira
    A. Spira
  • SKS.J. Klempner
    S.J. Klempner
  • MBM.A. Barve
    M.A. Barve
  • JCJ.G. Christensen
    J.G. Christensen
  • ACA. Chi
    A. Chi
  • HDH. Der-Torossian
    H. Der-Torossian
  • KVK. Velastegui
    K. Velastegui
  • TKT. Kheoh
    T. Kheoh
  • SOS-H.I. Ou
    S-H.I. Ou

Abstract
No abstract available